Methysergide treatment can continue with new restrictions

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has conducted a review of the use of methysergide and has made new recommendations following  reports of fibrosis seen with methysergide  use.   Fibrosis is a condition in which fibrous (scar) tissue accumulates in the body’s organs potentially damaging them.Read More